ClinicalTrials.Veeva

Menu

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

I

Instituto Valenciano de Infertilidad, IVI VALENCIA

Status

Completed

Conditions

Premature Luteinization

Treatments

Procedure: endometrial biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT00447850
VLC-EL-1006- 307-2

Details and patient eligibility

About

Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Oocyte donors
  • Age between 18-35 years old
  • BMI 18-29
  • NORMOGONADOTROPHICS
  • PROGESTERONE ≥ 1.2 ng/ml on hCG day

Exclusion criteria

  • PolyCystic Ovarian Syndrome (PCOS)
  • Endometriosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems